Unlock instant, AI-driven research and patent intelligence for your innovation.

Stable liquid pharmaceutical composition containing broadleaf holly leaf saponin compound

A technology of liquid medicine, picridin, which is applied in the field of liquid pharmaceutical compositions containing picridinic compounds, which can solve the problems of insignificant effects on survival rate and quality of life, damage to heart and kidney function, and large side effects

Pending Publication Date: 2022-06-21
SHANGHAI KE PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the short-term curative effects of these drugs are all significant, the effect on improving survival rate and quality of life is not obvious
The main reason is that the side effects of these drugs are large, and there is a certain damage to heart and kidney function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable liquid pharmaceutical composition containing broadleaf holly leaf saponin compound
  • Stable liquid pharmaceutical composition containing broadleaf holly leaf saponin compound
  • Stable liquid pharmaceutical composition containing broadleaf holly leaf saponin compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0106] According to the preparation formula in Table 1, take the water for injection of the formula amount, add disodium hydrogen phosphate, potassium dihydrogen phosphate, and disodium edetate in the formula amount, stir evenly, adjust the pH to about 7, and make a buffer solution; at the same time Weigh the formula amount of ethanol and Tween 80, add a part of the prepared buffer solution into it, stir evenly, prepare a solution with an ethanol concentration of about 50%, add the formula amount of picroside A to it, and stir until completely dissolved ; Finally, add the rest of the buffer and stir well. Obtained 3 formulation preparations.

[0107] Table 1: Formulation of formulations

[0108]

[0109] (2) Filling

[0110] Blowing, filling and sealing (BFS) integrated production line is used for filling, and 3 formulations of 3 different thicknesses (0.6mm, 1.0mm, 1.2mm) of low density polyethylene (Low Density Polyethylene, LDPE) bottle, 2ml per bottle.

[0111] (3) ...

Embodiment 2

[0120] Low-density polyethylene bottles (LDPE bottles) produced by the blow-fill-seal method are now used for inhalation preparations as packaging materials for direct contact with drugs. The bottle is easy and other advantages. However, the semi-permeability of LDPE bottles will cause the content of certain solvents (such as ethanol) stored in them to decrease due to volatilization. Due to the decrease of ethanol content, the solubility of the active compound KA decreases, which eventually leads to the precipitation of KA. Therefore, the inventors need to prevent the volatilization of ethanol to enhance the stability of the preparation and prolong its storage time. To this end, the inventors explored the stability of ethanol content in different sample formulations in Table 2.

[0121] Take the 9 kinds of KA preparation samples obtained in Table 2 of Example 1 and carry out the stability test of ethanol content to explore the change of ethanol content in the preparation unde...

Embodiment 3

[0146] Select sample 6 shown in embodiment 1 for use, carry out stability test by the condition shown in table 7:

[0147] Table 7: Stability test conditions

[0148]

[0149]

[0150] The content of KA was determined according to the external standard method in the general rule 0512 high performance liquid chromatography of "Chinese Pharmacopoeia" (2020 edition, volume four). Wherein, the chromatographic condition parameters used in high performance liquid chromatography are as follows:

[0151] Chromatographic column: C18 (2.1*100mm, 1.8μm);

[0152] Mobile phase: acetonitrile: water (26:74);

[0153] Flow rate: 0.6mL / min;

[0154] Column temperature: 38°C;

[0155] Detection wavelength: 225nm;

[0156] Injection volume: 5 μL;

[0157] Elution time: 28min.

[0158] According to the "Chinese Pharmacopoeia" (2020 Edition, Volume 4) general rule 0512 high performance liquid chromatography, the principal component self-control method with a correction factor was add...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Thicknessaaaaaaaaaa
Wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a stable liquid pharmaceutical composition containing a broadleaf holly leaf saponin compound. The stable liquid pharmaceutical composition comprises a therapeutically effective amount of broadleaf holly leaf saponin compound, a buffer effective amount of a buffer solution with the pH value of 6.5-7.5 and a pharmaceutically acceptable carrier. The liquid pharmaceutical composition disclosed by the invention is suitable for being stored in a semi-permeable container for a long time. The semi-permeable container is preferably a combination of a low-density polyethylene bottle and a medicinal aluminum foil bag, and the space between the low-density polyethylene bottle and the medicinal aluminum foil bag is in a vacuum state or an approximately vacuum state.

Description

technical field [0001] The invention belongs to the field of chemical pharmacy, and in particular relates to a stable liquid pharmaceutical composition containing picrinoid saponins. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is chronic bronchitis or emphysema characterized by airflow obstruction, which can progress to cor pulmonale and respiratory failure. The characteristic pathological changes of COPD include lung parenchyma damage and small airway fibrosis caused by chronic inflammation of the small airways and lungs caused by exposure to bacteria and gases, oxidative stress, and increased proteases. The morbidity and mortality of COPD have been increasing with the changes in the global environment and the age structure of the world's population. The incidence rate of people over 40 years old in the world has reached 9% to 10%, which has a serious impact on the lives and work of patients. [0003] At present, COPD is mainly treated with d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61K36/185A61K9/08A61K9/10A61K47/02A61K47/18A61K47/26A61P11/00A61J1/05
CPCA61K31/7048A61K36/185A61K9/08A61K9/10A61K9/007A61K47/26A61K47/183A61K47/02A61P11/00A61J1/05A61J1/065A61J1/10A61J1/16A61K47/10A61K9/0078A61K9/008A61K31/56
Inventor 马明
Owner SHANGHAI KE PHARMA CO LTD